Compare ALGN & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALGN | CAVA |
|---|---|---|
| Founded | 1997 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 10.6B |
| IPO Year | 2000 | 2023 |
| Metric | ALGN | CAVA |
|---|---|---|
| Price | $184.95 | $77.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 23 |
| Target Price | ★ $199.82 | $91.00 |
| AVG Volume (30 Days) | 980.6K | ★ 2.8M |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.53 | N/A |
| EPS | ★ 1.57 | 0.20 |
| Revenue | $387,126,000.00 | ★ $1,179,664,000.00 |
| Revenue This Year | $5.78 | $25.71 |
| Revenue Next Year | $4.62 | $20.57 |
| P/E Ratio | ★ $117.47 | $383.55 |
| Revenue Growth | ★ 23.95 | 22.41 |
| 52 Week Low | $122.00 | $43.41 |
| 52 Week High | $208.31 | $98.79 |
| Indicator | ALGN | CAVA |
|---|---|---|
| Relative Strength Index (RSI) | 58.30 | 42.95 |
| Support Level | $164.69 | $72.20 |
| Resistance Level | $199.75 | $90.00 |
| Average True Range (ATR) | 7.53 | 4.10 |
| MACD | 0.69 | -0.63 |
| Stochastic Oscillator | 90.49 | 6.88 |
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.